IllnessTumour intersecting set panel
Summary
Short information
An especially assembled panel comprising 29 kurated genes
ID
TP0815
Number of genes
29
Accredited laboratory test
Examined sequence length
0,0 kb (Core-/Core-canditate-Genes)
87,1 kb (Extended panel: incl. additional genes)
87,1 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
- EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications
NGS +
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
APC | 8532 | NM_000038.6 | AD | |
ATM | 9171 | NM_000051.4 | AD, AR | |
BAP1 | 2190 | NM_004656.4 | AD | |
BMPR1A | 1599 | NM_004329.3 | AD | |
BRCA1 | 5592 | NM_007294.4 | AD, AR, Mult, SMu, Sus | |
BRCA2 | 10257 | NM_000059.4 | AD, AR, SMu, Sus | |
BRIP1 | 3750 | NM_032043.3 | AD, Sus | |
CDH1 | 2649 | NM_004360.5 | AD | |
CDK4 | 912 | NM_000075.4 | AD | |
CDKN2A | 471 | NM_000077.5 | AD, Sus | |
CHEK2 | 1632 | NM_007194.4 | AD | |
EPCAM | 945 | NM_002354.3 | AD | |
GREM1 | 555 | NM_013372.7 | AD | |
HOXB13 | 855 | NM_006361.6 | n.k. | |
MLH1 | 2271 | NM_000249.4 | AD, AR, Sus | |
MSH2 | 2805 | NM_000251.3 | AD, AR, Sus | |
MSH6 | 4083 | NM_000179.3 | AD, AR, Sus | |
MUTYH | 1650 | NM_001128425.2 | AR, Sus | |
PALB2 | 3561 | NM_024675.4 | AD | |
PALLD | 3372 | NM_016081.4 | Sus | |
PMS2 | 2589 | NM_000535.7 | AD, Sus, AR | |
POLD1 | 3324 | NM_002691.4 | AD | |
POLE | 6861 | NM_006231.4 | AD, Sus | |
PTEN | 1212 | NM_000314.8 | AD, AR | |
RAD51C | 1131 | NM_058216.3 | AD | |
RAD51D | 987 | NM_002878.4 | AD | |
SMAD4 | 1659 | NM_005359.6 | AD | |
STK11 | 1302 | NM_000455.5 | AD | |
TP53 | 1182 | NM_000546.6 | AD |
Informations about the disease
Synonyms
- Alias: Solid cancer predisposition genes
- Allelic: Adrenal adenoma, somatic (MEN1)
- Allelic: Angiofibroma, somatic (MEN1)
- Allelic: Ataxia-telangiectasia (ATM)
- Allelic: Bone marrow failure syndrome 5 (TP53)
- Allelic: Cardiomyopathy, dilated, 1NN (RAF1)
- Allelic: Central hypoventilation syndrome, congenital (RET)
- Allelic: Fanconi anemia, complementation group S (BRCA1)
- Allelic: Hirschsprung disease, protection against + susceptibility to, 1 (RET)
- Allelic: Lhermitte-Duclos syndrome (PTEN)
- Allelic: Lipoma, somatic (MEN1)
- Allelic: Macrocephaly/autism syndrome (PTEN)
- Allelic: Melorheostosis, isolated, somatic mosaic (MAP2K1)
- Allelic: Metachondromatosis (PTPN11)
- Allelic: Multiple endocrine neoplasia 1 (MEN1)
- Allelic: Parathyroid adenoma, somatic (MEN1)
- Allelic: Pulmonary fibrosis and/or bone marrow failure, telomere-related, 4 (PARN)
- Adrenocortical carcinoma, pediatric (TP53)
- Basal cell carcinoma 7 (TP53)
- Breast cancer, somatic (TP53)
- Breast cancer, susceptibility to (ATM)
- Breast-ovarian cancer, familial, 1 (BRCA1)
- Carcinoid tumor of lung (MEN1)
- Cardiofaciocutaneous syndrome (BRAF)
- Cardiofaciocutaneous syndrome 3 (MAP2K1)
- Cardiofaciocutaneous syndrome 4 (MAP2K2)
- Cerebrooculofacioskeletal syndrome 4 (ERCC1)
- Cerebroretinal microangiopathy with calcifications + cysts (CTC1)
- Choroid plexus papilloma (TP53)
- Colorectal cancer (TP53)
- Cowden syndrome 1 (PTEN)
- DNA damage repair defect [panelapp] (ZNF668)
- Dyskeratosis congenita, AD 3 (TINF2)
- Dyskeratosis congenita, AD 6 (ACD)
- Dyskeratosis congenita, AR 6 (PARN)
- Dyskeratosis congenita, AR 7 (ACD)
- Dyskeratosis congenita, XL (DKC1)
- Fanconi anemia, complementation group D2 (FANCD2)
- Fanconi anemia, complementation group P (SLX4)
- Glioma susceptibility 1 (TP53)
- Glioma susceptibility 2 (PTEN)
- Hepatocellular carcinoma, somatic (TP53)
- IUGR, short stature, failure to thrive, body asymmetry [panelapp] (NLRP5)
- LEOPARD syndrome 1 (PTPN11)
- LEOPARD syndrome 2 (RAF1)
- LEOPARD syndrome 3 (BRAF)
- Li-Fraumeni syndrome (TP53)
- Lymphoma, B-cell non-Hodgkin, somatic (ATM)
- Lymphoma, mantle cell, somatic (ATM)
- Maternal effect gene causing phenotypes that include IUGR [panelapp] (NLRP2)
- Medullary thyroid carcinoma (RET)
- Meningioma (PTEN)
- Microcephaly, growth deficiency, global dev. delay, brain malformation [panelapp] (ZNF668)
- Multilocus imprinting disturbances [panelapp] (NLRP5)
- Multiple endocrine neoplasia IIA, IIB (RET)
- Nasopharyngeal carcinoma, somatic (TP53)
- Noonan syndrome 1 (PTPN11)
- Noonan syndrome 10 (LZTR1)
- Noonan syndrome 2 (LZTR1)
- Noonan syndrome 5 (RAF1)
- Noonan syndrome 7 (BRAF)
- Noonan syndrome 8 (RIT1)
- Noonan syndrome 9 (SOS2)
- Noonan syndrome-like disorder with loose anagen hair 2 (PPP1CB)
- Osteosarcoma (TP53)
- Pancreatic cancer, somatic (TP53)
- Pancreatic cancer, susceptibility to, 4 (BRCA1)
- Pheochromocytoma (RET)
- Prostate cancer, somatic (PTEN)
- Renal cell carcinoma, papillary (PRCC)
- Revesz syndrome (TINF2)
- Schwannomatosis-2, susceptibility to (LZTR1)
- T-cell prolymphocytic leukemia, somatic (ATM)
- Xeroderma pigmentosum, group E, DDB-negative subtype (DDB2)
Heredity, heredity patterns etc.
- AD
- AR
- Mult
- SMu
- Sus
- n.k.
OMIM-Ps
- Multiple OMIM-Ps
ICD10 Code
Bioinformatics and clinical interpretation
No text defined